Comparing Darzalex Faspro vs Tecvayli
| Darzalex Faspro (daratumumab / hyaluronidase) | Tecvayli (teclistamab) |
|
|---|
| Darzalex Faspro (daratumumab / hyaluronidase) | Tecvayli (teclistamab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Darzalex Faspro is a combination injection containing daratumumab and hyaluronidase-fihj which may be used to treat Multiple Myeloma and Light Chain (AL) amyloidosis usually in combination with... View more |
Prescription only
Prescribed for Multiple Myeloma. Tecvayli may also be used for purposes not listed in this medication guide. |
Related suggestions Multiple Myeloma
|
|||||||||||||||
| More about Darzalex Faspro (daratumumab / hyaluronidase) | More about Tecvayli (teclistamab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Darzalex Faspro has an average rating of 8.3 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Tecvayli has an average rating of 9.4 out of 10 from a total of 5 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Darzalex Faspro side effects |
View all Tecvayli side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Darzalex Faspro prices |
View all Tecvayli prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
480 hours |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 270 drugs are known to interact with Darzalex Faspro:
|
A total of 428 drugs are known to interact with Tecvayli:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
October 25, 2022 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.